Publikationen

Sharifan, A.; Harrod, C.S.; Dobrescu, A.; Gartlehner, G.; (2026). Area under the likelihood curve as a measure of evidential weight in nonsignificant meta-analyses: a meta-epidemiological study. Journal of Clinical Epidemiology, 197: 112356

Sharifan, A.; Harrod, C.; Dobrescu, A.; Gartlehner, G. (2026). Reverse fragility index shows high fragility in Cochrane meta-analyses with P values between 0.05 and 0.20: a meta-epidemiological study. Journal of Clinical Epidemiology, 195: https://doi.org/10.1016/j.jclinepi.2026.112285

Ledinger, D.; Todhunter-Brown, A.; Smith, M., Griebler, U.; Pollock, D.; Rees, R.; Tricco, A.C.; Dawson, S.; Macura, B.; Staniszewska, S.; Boddy, K.; Gartlehner, G.; Nussbaumer-Streit, B. (2026). Top 20 research priorities on methods of coproduction in evidence synthesis. Journal of Clinical Epidemiology, 195: https://doi.org/10.1016/j.jclinepi.2026.112286

Sharifan, A.; Harrod, C.; Dobrescu, A.; Gartlehner, G. (2026). Evaluating evidential strength of statistically nonsignificant meta-analyses with likelihood ratios: a meta-epidemiological study. Journal of Clinical Epidemiology, 195: https://doi.org/10.1016/j.jclinepi.2026.112297

Neubauer-Bruckner, C.; Sommer, I.; Fangmeyer, M.; Klerings, I.; Biesty, L.; Cooper, C.; Stummer, H. (2026). Midwives' and obstetricians' perspectives on collaborative practice in antenatal care: a qualitative systematic review protocol. JBI Evidence Synthesis, 24(6): 1256-1263

GBD 2023 Iran Collaborators; Sharifan, A.; et. al. (2026). Burden of 292 causes of death and life expectancy decomposition in Iran, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Global Health, 14(5): e734-e748

Griebler, U.; Klerings, I.; Koscher-Kien, C.; Lutz, B.; Krczal, E.; Ledinger, D.; Mair, I.; Emprechtinger, R.; Keser Aschenberger, F.; Kerschner, B. (2026). Development of a Validated Lay Checklist (Info Without Side Effects) for Assessing Health Information on Websites: Mixed Methods Study. Journal of Medical Internet Research, 28: e69529

GBD 2023 Maternal Mortality Collaborators; Sharifan, A. (2026). Global, regional, and national levels and trends in maternal mortality, progress towards the Sustainable Development Goals, and mortality from COVID-19 infection in pregnant women, 1990–2023: a systematic analysis for the Global Burden of Disease Study 23. Lancet Obstet Gynaecol Womens Health, 2 (5): e375-e424

Grillich, L.; Seidl, K.; Pell, A.; Nikitin, J.; Laireiter, A.R. (2026). Developing Quality Criteria for Community-Based Loneliness Interventions in Older Adults: An Evidence-Informed Framework. Journal of Prevention, https://doi.org/10.1007/s10935-026-00926-6: https://doi.org/10.1007/s10935-026-00926-6

Sharifan, A.; Fonarow, G.C. (2026). Statistical Misinterpretation of Nonsignificant Results in Diabetes Randomised Clinical Trials. Diabetes Metabolism Research and Reviews, 4: e70179

GBD 2023 Meningitis & Antimicrobial Resistance Collaborators; Sharifan, A. (2026). Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Neurology, 25(5): P451-468

GBD 2023 Mental Disorder Collaborators; Sharifan, A.; et. al. (2026). Updated trends in the global prevalence and burden of mental disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet, 407: 2040-64

Mitterbauer, N.; Hebesberger, D.V.; Daxenbichler, J.; Seidl, K.; Klerings, I.; Koscher-Kien, C.; Griebler, U. (2026). Missing men – why health promotion leaves them behind and how to bring them on board: results of a rapid qualitative evidence synthesis. BMC Public Health, 26: 1944

Braun, A.; Angerer, S.; Latzke, M. (2026). Structural social capital and cognitive decline in Europe: longitudinal evidence from the Survey of Health, Ageing and Retirement in Europe. Aging & Mental Health, https://doi.org/10.1080/13607863.2026.2672101: 1–14

Helfer, B.; Henke-Ciazynska, K.; Boyle, R.J. (2026). Operation Stork Speed represents an opportunity to reform infant formula clinical trials. Nature Food, https://doi.org/10.1038/s43016-026-01357-6: https://doi.org/10.1038/s43016-026-01357-6

Affengruber, L.; Emprechtinger, R.; Persad, E.; Kleijnen, J.; Gartlehner, G. (2026). Characteristics of studies falsely excluded during single-reviewer abstract screening: a meta-epidemiological analysis. BMC Medical Research Methodology, 26:117: https://doi.org/10.1186/s12874-026-02838-9

Sharifan, A.; Gadinger, A.; Cooper, C.; Braun, A. (2026). Vitrectomy After Cataract Surgery as a Patient Safety Indicator: A Rapid Review to Support Benchmarking Within the Austrian Inpatient Quality Indicators Framework. Journal of Patient Safety, 10.1097: 1-11

Sharifan, A.; Dobrescu, A.I.; Klerings, I.; Gartlehner, G. (2026). Update Alert 4: Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder: A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians. Annals of Internal Medicine, Online ahead of print: 10.7326/ANNALS-26-00504.

Moser, T.K.; Dobrescu, A.I.; Sommer, I.; Goeschl, S.; Sharifan, A.; Ledinger, D.; Klerings, I.; Gartlehner, G. (2026). Efficacy, Comparative Effectiveness, and Harm of Respiratory Syncytial Virus Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians. Annals of Internal Medicine, Online ahead of print: 10.7326/ANNALS-25-05536.

GBD 2021 AEMT Collaborators; Sharifan, A. (2026). Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021. Korean J Intern Med, 41(2): 350-366